Le Lézard
Classified in: Health
Subjects: CALENDAR OF EVENTS, HEALTH, Conference Calls/ Webcasts

Xenon Pharmaceuticals to Present at Leerink Partners Global Biopharma Conference 2024


VANCOUVER, British Columbia, March 05, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that the company will present at Leerink Partners Global Biopharma Conference 2024 to be held in Miami, FL on March 11-13, 2024.

Company Fireside Chat Presentation Details:

Date:Monday, March 11, 2024
  
Time:11:20 AM Eastern Time
  
Webcast:Register here
  
Presenters:Ian Mortimer, President and Chief Executive Officer
 Sherry Aulin, Chief Financial Officer
  

A live webcast of the company presentation will be available on the "Investors" section of Xenon's website and posted for replay following the event. The above listed dates and times are subject to change.

About Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals (Nasdaq:XENE) is a neuroscience-focused biopharmaceutical company committed to discovering, developing, and commercializing innovative therapeutics to improve the lives of people living with neurological and psychiatric disorders. We are advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. For more information, please visit www.xenon-pharma.com.

"Xenon" and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.

Contacts:
For Investors:
Chad Fugere
Vice President, Investor Relations
(857) 675-7275
[email protected]

For Media:
Jodi Regts
Xenon Corporate Affairs
(604) 484-3353
[email protected]



These press releases may also interest you

at 16:05
Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today reported the grant of...

at 15:47
The Eleanor Crook Foundation and Mana Nutrition Applaud the U.S. Government's Continued Leadership in Combating Child Malnutrition with $200 Million Commitment for Ready-to-Use Therapeutic Food
Today, U.S. Agency for International Development Administrator Samantha Power forged ahead in the fight against child malnutrition by announcing a $200 million investment in the procurement and distribution of Ready-to-Use Therapeutic Food (RUTF) ? a...

at 15:30
To ensure the implementation of a new pathway - The Town of Hudson announces the closure of Sandy Beach for the 2024 summer season
The Town of Hudson wishes to inform the public that it is obliged to close Sandy Beach for the summer of 2024. The trails leading to this beach are currently on private property and are no longer accessible to the public. The Town of Hudson must now...

at 15:19
FDA Roundup: May 03, 2024
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced the availability of draft guidance for industry (GFI) #290 (VICH GL61) entitled "Pharmaceutical Development"...

at 15:18
Registration Now Open for 'A Different Way to CE!'
'A Different Way to CE' is back for the fourth year in Nashville, Tennessee! The annual continuing education veterinary conference, sponsored by Nutramax Laboratories Veterinary Sciences, Inc., welcomes veterinary professionals and students from...

at 15:17
Closure of inpatient care unit at SBGHC's Durham Hospital sparks community outrage
In a move that has raised serious concerns about the future of rural health care and ignited widespread criticism from local residents, healthcare professionals and advocacy groups, South Bruce Grey Health Centre (SBGHC) has announced the decision to...

More news about Health...


News published on and distributed by: